Sesen Bio Inc
SESN.O- Latest Trade
- trading lower0.81USD
- Change
- -0.01
- % Change
0.89%Negative
- Day Range
- 0.78 - 0.82
- 52-Week Range
- 0.36 - 6.04
As of Jun 29 2022. Values delayed up to 15 minutes
- Previous Close
- 0.82
- Open
- 0.81
- Volume
- 994,692.00
- 3 Month Average Trading Volume
- 115.66
- Shares Out (Mil)
- 199.46
- Market Cap
- 162.38
- Forward P/E
- -2.04
- Dividend Yield
- -99,999.99
Key Statistics
2 mean rating - 2 analysts
- P/E Excl. Extra Items (TTM)
- 3.23
- Price To Sales (TTM)
- 7.30
- Price To Book (Quarterly)
- 0.94
- Price To Cash Flow (Per Share TTM)
- 2.98
- Total Debt/Total Equity (Quarterly)
- 0.00
- Long Term Debt/Equity (Quarterly)
- 0.00
- Return On Investment (TTM)
- 28.14
- Return On Equity (TTM)
- 26.38
2021 (millions USD)
About Sesen Bio Inc
Company Information
Sesen Bio, Inc. is a late-stage clinical company engaged in advancing targeted fusion protein therapeutics (TFPTs) for the treatment of patients with cancer. The Company's product candidates are based on its TFPT platform and are focused on addressing areas of unmet medical need in cancer. TFPTs are single protein therapeutics composed of targeting domains genetically fused via peptide linkers to cytotoxic protein payloads that are produced through its recombinant one-step, microbial manufacturing process. The Company’s advanced product candidate Vicinium, also known as VB4-845, which is composed of an anti-epithelial cell adhesion molecule (EpCAM) antibody fragment tethered to a truncated form of Pseudomonas exotoxin A for the treatment of bacillus calmette-guerin (BCG)-unresponsive non-muscle invasive bladder cancer (NMIBC).
Address
245 1st St Ste 1800CAMBRIDGE, MA
02142-1292
United States
Industry
Biotechnology & Drugs
Executive Leadership
- Jay S. Duker
- Independent Chairman of the Board
- Thomas R. Cannell
- President, Chief Executive Officer, Director
- Monica Forbes
- Chief Financial Officer, Treasurer
- Glen C. MacDonald
- Chief Technology Officer
- Elly Ryu
- Chief Accounting Officer, Controller
- Mark R. Sullivan
- General Counsel, Corporate Secretary
- Minori Rosales
- Chief Development Officer
- Carrie L. Bourdow
- Independent Director
- Peter K. Honig
- Independent Director
- Michael A.S. Jewett
- Independent Director
- Jason A. Keyes
- Independent Director
Latest News
- MarketsBlue Apron, Baker Hughes, Luminar, cruise cos
U.S. stock indexes rose on Thursday on strong earnings reports, while bargain hunting boosted mega-cap growth companies after the Nasdaq index plunged into correction territory in the previous session.
- MarketsGold stocks, Acer Therapeutics, Cvent, Apple, Jupiter Wellness
U.S. stock indexes slipped on Thursday after three straight days of gains following positive updates on the Omicron coronavirus variant, with focus now turning towards inflation data for clues on the Federal Reserve's policy decision.
Markets Performance
Official Data PartnerCommodities
| Future | Last | % Change |
|---|---|---|
| Gold | 1,813.70 | -- |
| Copper | 694.25 | 1.57%Negative |
| Brent Crude Oil | 116.26 | -- |
| CBOT Soybeans | 1,674.25 | -- |
Stocks
| Index | Last | % Change |
|---|---|---|
| S&P 500 | 3,818.83 | 0.07%Negative |
| Euro STOXX 50 | 3,514.32 | 0.99%Negative |
| FTSE 100 | 7,312.32 | 0.15%Negative |
| Nikkei 225 | 26,804.60 | -- |
Source: Refinitiv, an LSEG business - data delayed by at least 15 minutes